NHS ester-PEG8-Val-Cit-PAB-MMAF
PG-20161-57505
Product information
- Catalog No.
- PG-20161-57505
- Product Name
- NHS ester-PEG8-Val-Cit-PAB-MMAF
- CAS No.
- Not specified
- Molecular Formula
- C82H131N11O26
- Molecular Weight
- 1687
- Purity
- 90%
- Storage
- -20°C
- Shipping
- Ambient Temperature
- Documents
Missing values are marked “Not specified”. Request the technical information you need with your inquiry. For research use only.
Packaging & pricing
| Catalog No. | Packaging | Price (USD) | Stock | Inquiry action |
|---|---|---|---|---|
| PG-20161-57505 | 10 MG | Inquiry | In stock | |
| PG-20161-57505 | 25 MG | Inquiry | In stock | |
| PG-20161-57505 | 50 MG | Inquiry | In stock |
Final pricing, package availability and delivery are confirmed with your quotation.
General Information
- Product Name
- NHS ester-PEG8-Val-Cit-PAB-MMAF
- CAS No.
- Not specified
- Synonyms
- Not specified
- Molecular Formula
- C82H131N11O26
- Molecular Weight
- 1687
- Appearance
- Not specified
- Solubility
- Not specified
- Description
NHS ester-PEG8-Val-Cit-PAB-MMAF is a cleavable linker–payload compound for antibody-drug conjugate (ADC) research. It combines the antitubulin agent MMAF with a Val-Cit sequence cleavable by Cathepsin B. MMAF inhibits tubulin polymerisation, disrupting cell division.
The terminal NHS ester enables coupling to amine groups, while the PEG8 segment supports increased aqueous solubility of the conjugate. The compound is listed within the ADC linker catalog under MMAF payloads and cleavable Val-Cit-MMAF linkers.